Form 4/A for GANX Gain Therapeutics, Inc.
Accepted 2022-04-21 00:00:00 ET · period of report 2021-08-16 · accession 0001209191-22-025180 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-04-21 | 2021-08-16 | GANX | RICHMAN ERIC I | CEO, Dir | P - Purchase | $7.87 | +4,922 | 216.8K | +2% | +$38.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | P | A | 4,922 | $7.87 | 216,820 | D | — | — |